Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 1/20 | 0.31 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.31 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.31 |
| ▸ | NR2E1 | Q9Y466 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19607447 | 0.81 | — | — | |
| SCHEMBL19542989 | 0.81 | ADRB2 (0.31) | ADRB2ADRB1ADRB3NR2E1 | |
| SCHEMBL25144632 | 0.75 | ADH1B (0.30) | — | |
| SCHEMBL25144614 | 0.73 | TSHR (0.40) | ADRB2ADRB1ADRB3 | |
| SCHEMBL18016561 | 0.73 | ADRB2 (0.31) | ADRB2ADRB1ADRB3 | |
| SCHEMBL21788090 | 0.73 | ADRB2 (0.33) | ADRB2ADRB1ADRB3 | |
| SCHEMBL21788145 | 0.73 | ADRB2 (0.33) | ADRB2ADRB1ADRB3 | |
| SCHEMBL18016546 | 0.72 | — | — | |
| SCHEMBL25144721 | 0.70 | ADRB2 (0.34) | ADRB2ADRB1ADRB3 | |
| SCHEMBL25144825 | 0.70 | ADRB2 (0.34) | ADRB2ADRB1ADRB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11173144-B2 | Adrenergic receptor modulating compounds and methods of using the same | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2021-11-16 | — | — | US | disclosed |
| US-20200237724-A1 | ADRENERGIC RECEPTOR MODULATING COMPOUNDS AND METHODS OF USING THE SAME | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2020-07-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200237724-A1 | ADRENERGIC RECEPTOR MODULATING COMPOUNDS AND METHODS OF USING THE SAME | ADRB1, ADRB2, ADRA1B | ADRB2 2/4885ADRB1 1/4885ADRB3 9/4885 |
| US-11173144-B2 | Adrenergic receptor modulating compounds and methods of using the same | ADRB1, ADRB2, ADRA1B | ADRB2 2/4885ADRB1 1/4885ADRB3 9/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.